Tiagabine in the treatment of epilepsy — a clinical review with a guide for the prescribing physician
- 24 August 2000
- journal article
- review article
- Published by Elsevier in Epilepsy Research
- Vol. 41 (3) , 245-251
- https://doi.org/10.1016/s0920-1211(00)00149-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizuresEpilepsy Research, 1998
- TiagabineDrugs, 1998
- Effect of Renal Impairment on the Pharmacokinetics and Tolerability of TiagabineEpilepsia, 1998
- Pharmacokinetics and Safety of Tiagabine in Subjects with Various Degrees of Hepatic FunctionEpilepsia, 1997
- Cognitive and quality of life effects of differing dosages of tiagabine in epilepsyNeurology, 1997
- A single‐dose study to define tiagabine pharmacokinetics in pediatric patients with complex partial seizuresNeurology, 1997
- Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsyEpilepsy Research, 1996
- Pharmacokinetics of Tiagabine, a γ‐Aminobutyric Acid‐Uptake Inhibitor, in Healthy Subjects After Single and Multiple DosesEpilepsia, 1995
- Tiagabine Pharmacology in ProfileEpilepsia, 1995
- Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1European Journal of Pharmacology: Molecular Pharmacology, 1994